MedTrace Logo

Hydrocortisone Per-treatment Decrease Side Effects of Protamine Sulfate

NCT04435912 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-06-17

No results posted yet for this study

Summary

This study aims to compare the hemodynamic parameters within and between patients who received Protamine Sulfate (PS) with Hydrocortisone (HC) vs. Protamine Sulfate alone during cardiac surgeries.

Conditions

  • Blood Pressure
  • Heart Rate
  • Airway Pressure

Interventions

DRUG

Hydrocortisone 200mg IV

single dose pre-treatment given IV given at the time when the patient is attached to the cardiopulmonary bypass machine

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Mustafa A Alrabayah, MD · The University of Jordan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-04
Primary Completion
2020-04-30
Completion
2020-06-01
FDA Drug
Yes

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04435912 on ClinicalTrials.gov